Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients
Herbert A. Hauer(Leiden University Medical Center), E. Christiaan Hagen(Leiden University Medical Center), Franco Ferrario(Azienda Ospedaliera San Gerardo), David Jayne(University of Cambridge), Ingeborg M. Bajema(University Medical Center Groningen), Hans C. van Houwelingen(Leiden University), Niels Rasmussen(University of Copenhagen), Laure‐Hélène Noël(Délégation Paris 5), Rüdiger Waldherr(Praxis für Humangenetik), Jan A. Bruijn(Leiden University Medical Center)
Cited by 222
Related Papers
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
|Journal of the American Society of Nephrology|2004|2k
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
|New England Journal of Medicine|2010|1.7k
Pathologic Classification of Diabetic Nephropathy
|Journal of the American Society of Nephrology|2010|1.7k